Wren Therapeutics

This company, originating from the University of Cambridge and Lund University, is dedicated to addressing protein misfolding diseases. Leveraging a proprietary kinetics platform, it aims to develop small molecule therapeutics to treat these conditions. Its approach is based on the understanding of the kinetics of protein misfolding and aggregation.